Annals of Surgical Oncology

Papers
(The TQCC of Annals of Surgical Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
ASO Author Reflections: Pleural Thickness in Patients with Malignant Pleural Mesothelioma417
Is it a Pipeline Problem or a Selection Problem?125
ASO Visual Abstract: Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy 101
ASO Visual Abstract: Induction Chemotherapy with FOLFIRINOX for Locally Advanced Pancreatic Cancer: A Simple Scoring System to Predict Effect and Prognosis71
ASO Visual Abstract: Drug-Eluting Beads with Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin66
ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatme62
ASO Visual Abstract: Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Non-gynecologic Cancers61
ASO Visual Abstract: Distinct Failure Patterns in Hypopharyngeal Cancer Patients Receiving Surgery-Based Versus Radiation-Based Treatment61
Festschrift for Dr. Jeffrey A. Norton, 12–13 October 2023, Stanford, CA, USA57
ASO Author Reflections: Menopausal Status Does Not Predict Successful Breast Conservation Surgery After Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma56
ASO Visual Abstract: Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma54
ASO Visual Abstract: Racial Disparities in Time to Treatment Persist in the Setting of a Comprehensive Breast Center52
ASO Visual Abstract: The Role of Adjuvant Use of the PlasmaJet® Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer—Results of the PlaComOv-Study, a Randomized, Controlled Trial in 52
ANGPTL2: Is it a Novel Therapeutic Target Related to Tumor-Associated Macrophages in Esophageal Cancer?51
ASO Author Reflections: Management of Recurrent Pseudomyxoma Peritonei After Cytoreductive Surgery and HIPEC50
ASO Author Reflections: Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy50
Treatment Paradigm for Cervical Esophageal Cancer: Now and Then49
ASO Visual Abstract: Detecting Somatic Mutations for Well-Differentiated Pancreatic Neuroendocrine Tumors in Endoscopic Ultrasound-Guided Fine Needle Aspiration with Next-Generation Sequencing48
ASO Visual Abstract: Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients47
ASO Visual Abstract: Poor Access to Mental Healthcare is Associated with Worse Postoperative Outcomes among Patients with Gastrointestinal Cancer45
ASO Visual Abstract: Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study43
Perfusate Flow Rate: An Overlooked Factor in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?43
ASO Visual Abstract: Overuse of Axillary Surgery for Patients With Ductal Carcinoma In Situ: Opportunity for De-Escalation43
ASO Visual Abstract: Chronologic Age, Independent of Frailty, is the Strongest Predictor of Failure-to-Rescue After Surgery for Gastrointestinal Malignancies41
ASO Author Reflections: Total Three-Dimensional Guided Laparoscopic Radical Resection for Perihilar Cholangiocarcinoma—Transitioning from the Plane to the Realm of Dimensionality41
Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?41
ASO Author Reflections: Colonoscopic-Assisted Laparoscopic Wedge Resection Seems a Valuable Addition to the Current Local Resection Techniques in Case of Suspected Deep-Invasive T1 Colon Cancer40
ASO Visual Abstract: Para-aortic Lymph Node Dissection for Colorectal Cancer—Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes40
ASO Author Reflections: Potentially Avoidable and Prolonged Hospitalizations for Suspected Colon Cancer—Hospital Impact38
ASO Author Reflections: A Multiomic Novel Staging System for Esophageal Squamous Cell Carcinoma Patients37
Is it Time for Synoptic Reporting in Melanoma Nodal Surveillance Ultrasonography?37
ASO Visual Abstract: Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients37
ASO Author Reflections: Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders37
Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting: Time to Collaborate for Universal Consensus and Training Programs37
Significance of Specimen Extraction Site in Minimizing Hernia Risk After Distal Pancreatectomy36
Authors’ Response to the Letter to the Editor “Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Met36
ASO Author Reflections: Clinical Outcome After Upfront Curative-Intent Local Treatment of Metastases in Patient with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal C36
ASO Visual Abstract: Factors Associated with 1-Year Mortality of Elderly Patients (Age 80 Years and Older) with Cancer Undergoing Major Abdominal Surgery: A Retrospective Cohort Study36
ASO Visual Abstract: Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70? A National Cancer Database (NCDB) Analysis of Sentinel Node Practice Patterns36
Breast Cancer Genes and Contralateral Prophylactic Mastectomy: Beyond BRCA35
ASO Visual Abstract: Accuracy and Survival Outcomes After National Implementation of Sentinel Lymph Node Biopsy in Early-Stage Endometrial Cancer35
ASO Visual Abstract: Cryoablation Allows the Ultimate De-escalation of Surgical Therapy in Select Breast Cancer Patients34
ASO Visual Abstract: Outcomes and Trends in Axillary Management of Patients with Stage cN3b Breast Cancer34
ASO Author Reflections: Can Nodal Features Improve Treatment Response Prediction in Esophageal Cancer?34
Comparing Apples to Oranges: Commentary on a Secondary Analysis of SWOG 080934
ASO Visual Abstract: Peritoneal Metastases of Colorectal Origin Treated with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy—The Efficiency of Mitomycin C34
ASO Visual Abstract: Venous Thromboembolic Event Following Soft Tissue Sarcoma Diagnosis is Associated with the Development of Pulmonary Metastasis33
ASO Author Reflections: Longitudinal Relief of Patient-Report Dysphagia in Esophageal Cancer33
ASO Author Reflections: Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights from a Multi-center Study32
ASO Visual Abstract: Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy—Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management32
ASO Visual Abstract: Defining Optimal Management of Nonmetastatic Adrenocortical Carcinoma32
Understanding Barriers to Enrollment in Adjuvant Clinical Trials: Insights into Patient Eligibility Criteria from the Adjuvant S-1 for Cholangiocarcinoma Trial (JCOG1202, ASCOT)32
ASO Visual Abstract: Laparoscopic Liver Tunnel for Tumors at the Hepatocaval Confluence32
ASO Author Reflections: Impact of RAS Mutations on Total Neoadjuvant Therapy Outcomes in Rectal Cancer32
ASO Visual Abstract: Long-Term Outcomes of Orthotopic Neobladder versus Ileal Conduit Urinary Diversion in Robot-Assisted Radical Cystectomy (RARC): Multicenter Results from the Asian RARC Consortium31
ASO Visual Abstract: Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype: A Systematic Review and Meta-Analysis Evaluating the Impact of Oncoplastic Surgery31
ASO Visual Abstract: The Role of Neoadjuvant Immunotherapy in the Management of Merkel Cell Carcinoma with Clinically Detected Regional Lymph Node Metastasis31
ASO Visual Abstract: Total Metastases Volume and Relative Volume Reduction After Neoadjuvant Therapy Predict Outcome After Liver Resection of Colorectal Liver Metastases31
ASO Author Reflections: The Evolving Role of Immunotherapy for Gastro-Esophageal Malignancies31
ASO Visual Abstract: Sarcoma Size and Limb Dimensions Predict Complications, Recurrence, and Death in Patients with Soft Tissue Sarcoma in the Thigh—A Multidimensional Analysis31
ASO Visual Abstract: Perioperative Complications and In-Hospital Mortality after Cystectomy for Non-Bladder Cancer Conditions versus Radical Cystectomy for Bladder Cancer31
Contrast-Enhanced Radiologic Evaluation of Gastric Conduit Emptying After Esophagectomy30
Reply to: Letter to Editor Regarding Article “A Machine Learning Approach to Predict Postoperative Pancreatic Fistula after Pancreaticoduodenectomy Using Only Preoperatively Known Data” by Yang, Yanfe30
ASO Visual Abstract: Biopsychosocial Late Effects After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal and Appendiceal Cancer: A National30
ASO Author Reflections: Expanding Minimally Invasive Options for Perihilar Cholangiocarcinoma: The Use of Robotic Platform in Biliovascular Reconstruction29
Breast Articles From 2023: Informing Practice Across the Continuum of Care29
ASO Visual Abstract: Population-Based Cohort Study from a Prospective National Registry-Better Long-Term Survival in Esophageal Cancer after Minimally Invasive Compared with Open Transthoracic Esophag28
ASO Author Reflections: Optimizing Treatment for Resectable Pancreatic Cancer: CA19-9 > 500 U/mL as a Biologic Indicator for Neoadjuvant Therapy28
Invited Editorial Regarding “Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors”, by Howe et al.28
Cross-Sectional Analysis of Patients Referred to a Tertiary Lymphatic Surgery Center28
ASO Visual Abstract: Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer—A National Cancer Database Study28
Recognizing Disparities in Breast Cancer Patient-Reported Outcome Measures28
ASO Visual Abstract: Shaving Papillary Thyroid Carcinoma Involving Functioning Recurrent Laryngeal Nerve—Safety of Incomplete Tumor Resection and Nerve Sparing28
ASO Visual Abstract: Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Mali28
Correspondence on “Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative 28
Great Debate: Chemoradiation Should be Added to Chemotherapy as a Neoadjuvant Treatment Strategy for Resectable Gastric Adenocarcinoma27
Near Complete Response: An Opportunity for Organ Preservation in Rectal Cancer27
ASO Visual Abstract: Augmenting the Future Liver Remnant Prior to Major Hepatectomy: A Review of Options on the Menu27
Risk Factors and Survival Analysis of Spontaneously Ruptured Hepatocellular Carcinoma: A Retrospective Cohort Study in Bilateral Centers27
Comparative Analysis of Long-Term Outcomes Between Near-Infrared Fluorescence Imaging with Indocyanine Green-Guided Mediastinal Lymphadenectomy and Conventional Surgery for Esophageal Cancer27
ASO Author Reflections: Chasing a Microscopic Cancer-Free Margin During Resection for Perihilar Cholangiocarcinoma: Can Additional Resection Improve the Long-Term Outcomes?27
Novel Risk Score Incorporating Type-IV Collagen, Albumin, and Prothrombin Time (CAP score) to Predict 180-Day Surgery-Related Mortality After Liver Resection for Hepatocellular Carcinoma27
ASO Visual Abstract: Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overall and by Adjuvant Chemotherapy Regimens27
Right Kidney Preservation During Resection of the Infrarenal Inferior Vena Cava for Paragangliomas27
ASO Author Reflections: The Evolving Evidence of Prehabilitation in Frail Cancer Patients Undergoing Surgery27
ASO Visual Abstract: Short-Term Outcomes of Breast Cancer Surgery by Race-Ethnicity in the Military Health System26
The Rule for Good Anastomosis: A Golden Ratio Between Thickness and Diameter26
The Impact of Lymphedema on Patient-Reported Outcomes After Breast Reconstruction: A Preliminary Propensity Score-Matched Analysis26
Combined Laparoscopic and Open Surgical Approach for Well Differentiated Trans-compartmental Liposarcoma Between Pelvic and Femoral Regions26
Three-Course Neoadjuvant Chemotherapy Associated with Unfavorable Survival of Non-responders to the First Two Courses for Locally Advanced Esophageal Cancer26
ASO Visual Abstract: Preoperative Systemic Immune-Inflammatory Index Predicts Occult Nodal Disease in Clinically Node-Negative Intrahepatic Cholangiocarcinoma26
Preoperative Fistula Risk Prediction Using Computed Tomography Image Before Pancreatoduodenectomy25
Retroperitoneoscopic Clampless, Sutureless Hybrid Therapy in the Management of Renal Hilar Tumors25
Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer25
Completely Resectable (cT1-2) Esophageal Squamous Cell Carcinoma with Minimal Lymph Node Involvement (cN1): Is Neoadjuvant Chemoradiation Therapy the Only Viable Treatment Option?25
Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer25
ASO Author Reflections: Tailoring Surgery in CSCC: A New Era of Response-Adapted Treatment25
ASO Visual Abstract: The Association of Clinical Stage at Presentation with Overall Survival in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy25
Distribution and Rate of Myxoid Liposarcoma Spine Metastases: Impact on Surveillance Imaging25
ASO Visual Abstract: Expression of Signal Regulatory Protein Alpha in Tumor Cells is the Key Factor in Intrahepatic Cholangiocarcinoma25
Do Patients with DCIS or Invasive Breast Cancer Carry the Same Risk for Genetic Mutation?25
Variation in Cost Centers Following Gastrointestinal Cancer Surgery25
ASO Visual Abstract: Preoperative Radiation Boosts Results in Low Rates of Re-Excision and Reduced Locoregional Treatment Time for Breast Cancer Patients25
Compartmental Transoral Robotic Lateral Oropharyngectomy with the da Vinci Single-Port System: Surgical Technique24
Harnessing Machine Learning and Multiomics to Construct a Tumor-Specific T Cell Signature for Prognostic Assessment and Precision Medicine in Lung Adenocarcinoma24
ASO Author Reflections: Redefining Prognostic Endpoints in Intrahepatic Cholangiocarcinoma—The Role of Recurrence-Free Survival24
ASO Author Reflections: Step-Count During Hospitalization Reveals Postoperative Risk—Predicting Readmission After Esophagectomy24
Exploring Breast Surgeons’ Attitudes on Universal Genetic Testing: A Qualitative Study24
A New Method of Identifying Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Patients Using a Population-Based Electronic Medical Record System24
Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ24
ASO Visual Abstract: Role of Lateral Pelvic Lymph Node Dissection Following Neoadjuvant Chemoradiation Therapy in Rectal Cancer: A Multicenter Retrospective Study (KROG 22-09)24
Letter to the Editor Regarding "An Evidence-Based Staging System for Mucosal Melanoma: A Proposal”24
ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTIT24
Lymph Node Yield and Long-Term Mortality Risk in Patients with Colon Cancer: A 20-Year Follow-Up National Study24
Feasibility and Efficacy of Decision Aids to Improve Decision-Making for Contralateral Prophylactic Mastectomy: A Systematic Review23
Survival Benefits and Less Intensive Treatment for Women with Early-Stage Breast Cancer Diagnosed While Participating in Population-Based Screening23
Disaggregating Asian American and Pacific Islander Subpopulations in Esophageal Cancer: Stage, Histology, and Survival23
Complete Laparoscopic Type C2 Radical Surgery for Cervical Stump Cancer: No-Look and No-Touch Techniques23
ASO Author Reflections: The Role of the Clipped Node after Neoadjuvant Chemotherapy in the Contemporary Setting23
Reply to Letter to the Editor: Risk Factors and Survival Analysis of Spontaneously Ruptured Hepatocellular Carcinoma: A Retrospective Cohort Study in Bilateral Centers23
Downstaging Effect Rather than the Full Intended Cycles of Perioperative Chemotherapy Determines the Value of Adjuvant Chemotherapy in Gastric Cancer23
Favorable Prognostic Factors for Survival Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis After Hepatectomy23
Elevated Carcinoembryonic Antigen Levels Predict Failure to Reach Surgery in Patients with Borderline Resectable Pancreatic Cancer Referred to Neoadjuvant Therapy23
Surgical and Oncological Outcomes of Level III–IV Versus Level I–II Inferior Vena Cava Thrombectomy: A Decennial Experience of a High-Volume European Referral Center23
ASO Author Reflections: Innovative Superior Mesenteric Artery Approach in Robot-Assisted Pancreatoduodenectomy22
ASO Author Reflections: Preoperative Anaemia and Transfusion: What They Tell Us—and What They Do Not22
Nomogram Based on Pan-Immune Inflammation Value and Clinicopathological Parameters for Predicting the Recurrence of Endometrial Cancer and Providing Postoperative Prognostic Management22
Radiotherapy in Retroperitoneal Liposarcoma: Are We Looking for an Answer in the Wrong Place?22
ASO Visual Abstract: Does Splenic Hilar Lymph Node Harvesting Impact Outcomes following Total Gastrectomy for Cancer? A Multi-Institutional Retrospective Study with Propensity Score Matching22
Axillary Management Trends and Survival in Men Undergoing Mastectomy with Positive Sentinel Nodes22
Machine Learning-Driven Modeling to Predict Postdischarge Venous Thromboembolism After Pancreatectomy for Pancreas Cancer22
ASO Visual Abstract: Hepatic Recurrence Rate Based on Extent of Adjuvant Floxuridine Exposure After Resection of Colorectal Liver Metastases22
Impact of Tumor Size on the Survival Benefit of Anatomic Versus Non-Anatomic Resection for Intrahepatic Cholangiocarcinoma22
Extent and Boundaries of Lymph Node Stations During Minimally Invasive Esophagectomy: A Survey Among Dutch Esophageal Surgeons21
Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium21
Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data21
ASO Author Reflections: Democratizing Intraoperative Navigation through Simple CAD-Based 3D Modeling in HPB Surgery21
Is Thoracic Duct Resection Necessary for Esophageal Squamous Cell Carcinoma Patients Treated with Neoadjuvant Chemoradiotherapy? A Propensity-Matched Analysis Based on the Comprehensive Registry of Es21
ASO Visual Abstract: Complete Laparoscopic Type C2 Radical Surgery for Cervical Stump Cancer—No-Look and No-Touch Techniques21
ASO Author Reflections: Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma: A Landmarking-Based Analysis21
ASO Author Reflections: Smaller Tumors and Negative Nodes—Current Selection to Surgery in Multiple Intrahepatic Cholangiocarcinoma. A Future Role for Oncological Therapies to Improve Outcomes and Perm21
Salvage Metastasectomy After Adoptive Cell Transfer for Melanoma: Long-Term Updates21
Correction: Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma21
ASO Author Reflections: Artificial Intelligence-Augmented Detection of Bladder Tumors21
Intratumoral Bacteria are Uncommon in Gastrointestinal Stromal Tumor21
Correction: Risk Factors for Recurrence of Non-Small-Cell Lung Cancer After Anatomical Segmentectomy21
ASO Visual Abstract: The Value of Ultrasound in Patients with T1–T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial20
ASO Author Reflections: Perioperative and Oncologic Outcomes of Partial Versus Radical Nephrectomy for Complex Renal Tumors (RENAL Score ≥ 7): Systematic Review and Meta-Analysis20
ASO Visual Abstract: A Phase II Study of Short-Course Neoadjuvant Chemoradiotherapy with Gemcitabine, S-1, and Hypofractionated Radiotherapy for Resectable and Borderline Resectable Pancreatic Ductal 20
ASO Author Reflections: Semi-Structured Surgeon Interviews Regarding Axillary Management After Neoadjuvant Endocrine Therapy: Could They Lead to Consensus Guidelines?20
Editorial: Bridging Biology and Surgery: The Next Frontier in Managing Cytology-Positive Gastric Cancer20
Surgeon and Radiologist Evaluation of Electromagnetic Chip Localization for Benign and Malignant Breast Lesions20
Design and Validation of an Impaction-Nozzle Nebuliser for Enhanced Distribution Uniformity in Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) Applications20
Development and Validation of a Machine Learning-Based Predictive Model for Postoperative Frailty in Patients with Non-Small Cell Lung Cancer and Its Relation to Early Recovery20
ASO Author Reflections: Clinical Promise of Platinum Prophylactic Intraperitoneal Chemotherapy in Colorectal Cancer20
Continuous Wound Irrigation and Intraoperative Methadone Decreases Opioid Use and Shortens Length of Stay After CRS/HIPEC20
ASO Visual Abstract: Post-operative Impact of Closed Incision Negative Pressure Therapy Following Oncoplastic Breast Surgery20
Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy?20
ASO Author Reflections: A Novel Mechanism of Anticancer Effect of Skeletal Muscle-Derived Irisin in Pancreatic Ductal Adenocarcinoma19
ASO Author Reflections: Practice, Preference, and Price: Reflections on Alpha-Blockade Choices19
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® 19
Comparison of Short-Term Outcomes Between Robot-Assisted and Video-Assisted Segmentectomy for Small Pulmonary Nodules: A Propensity Score-Matching Study19
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial19
Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different Career Stages19
ASO Author Reflections: Advancing the Superior Mesenteric Arterial Divestment for Locally Advanced Pancreatic Cancer: New Standard Procedure and Future Prospectives19
Assessing Surgeon Familiarity with the Commission on Cancer Operative Standards for Cancer Surgery19
ASO Author Reflections: Delays in Breast Cancer Treatment During the COVID Pandemic—Disparities in Delay and a Call to Action19
Perioperative Complications and In-hospital Mortality After Cystectomy for Nonbladder Cancer Conditions Versus Radical Cystectomy for Bladder Cancer19
Protective Factors Associated with Normal Lymphatic Function After Axillary Lymph Node Dissection for Breast Cancer Treatment19
ASO Visual Abstract: Text-Based Intervention Increases Mammography Uptake at an Urban Safety-Net Hospital19
PneumoScore: Risk Prediction Model for 90-Day Mortality After Lung Resection19
Tailored Surgery for Medullary Thyroid Cancer (MTC) Based on Pretherapeutic Basal Calcitonin and Intraoperative Diagnosis of Desmoplastic Stroma Reaction: A Proposal for a New Surgical Concept19
Timing and Frequency of Surveillance After Resection of Extremity and Trunk Soft Tissue Sarcoma: Identifying Opportunities for Improvement19
Exploring the Potential of Robotic Single-Port Surgery for Gallbladder Cancer: Initial Insights and Future Prospects19
First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal Sarcomas18
Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype: A Systematic Review and Meta-analysis Evaluating the Impact of Oncoplastic Surgery18
ASO Visual Abstract: Integrating Generative AI into Nomograms for Breast Cancer Nodal Risk Predictions18
Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients18
ASO Visual Abstract: Minimizing Early-Onset Lymphedema After Groin Dissection in Metastatic Melanoma18
Leading Consortiums from the Ground Up: Leveraging Trainee Collaboration to Create Consensus Guidelines18
Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study18
The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Methodology18
ASO Visual Abstract: Enhanced Recovery After Liver Surgery: Does Compliance Impact Survival?18
Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer: A Retrospective Analysis18
Robotic Ureteroileal Bypass Repair for Post-Cystectomy Bricker Ureteroenteric Anastomotic Strictures: Stepwise Approach and Clinic Outcomes18
Robotic-Modified Taj Mahal Hepatectomy for Type IV Hilar Cholangiocarcinoma18
Clinical Features, Microbial Epidemiology, and Recurrence Risk of Cellulitis in Breast Cancer-Related Lymphedema18
ASO Visual Abstract: The Effect of Pathological Response to Preoperative Therapy on Margin Status and Outcomes After Resection of Colorectal Liver Metastases18
Circadian Rhythms in Cancer: Mechanistic Insights, Chronotherapeutic Strategies, and Translational Challenges18
Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer: A Matched-Pair Analysis18
Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms18
3D Specimen Scanning and Mapping in Musculoskeletal Oncology: A Feasibility Study18
ASO Visual Abstract: Volume-Outcome Relationships in Total Mesorectal Excision Quality and Grading: A National Cancer Database Study18
ASO Author Reflections: Adjuvant Chemotherapy in Poorly Differentiated Pancreatic Ductal Adenocarcinoma: Does Timing Impact Survival?18
Ileocecal and Small Bowel Involvement Are Independently Associated with Inferior Survival Despite Complete Cytoreduction in FIGO IIIC–IV Tubo-Ovarian and Primary Peritoneal Carcinoma18
The Key Role of Tumor Budding in Predicting the Status of Lymph Node Involvement in Early Gastric Cancer Patients: A Clinical Multicenter Validation in China18
Society of Surgical Oncology Consensus Statement: Assessing the Evidence for and Utility of Gene Expression Profiling of Primary Cutaneous Melanoma18
ASO Author Reflections: Minimally Invasive Surgery, Three-Dimensional (3D) Reconstruction and Indocyanine Green Fluorescence: The Perfect Combo to Enter the Era of Intraoperative Liver Navigation18
ASO Author Reflections: Circulating Tumor DNA as a Potential Emerging Biomarker in Malignant Phyllodes Tumors18
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group17
Potential Overtreatment of DCIS in Patients with Limited Life Expectancy17
Letter to the Editor: Circulating Exosomal MicroRNA Signature Predicts Peritoneal Metastasis in Patients with Advanced Gastric Cancer17
ASO Visual Abstract: The Association of Guideline-Concordant Sentinel Lymph Node Biopsy for Melanoma at Minority-Serving Hospitals17
Incremental Improvements in the Ability to Distinguish High-Risk Intraductal Papillary Mucinous Neoplasms17
ASO Author Reflections: Mainstream Genetic Testing Makes It Feasible for a Large Integrated System to Expand the Testing Eligibility in Breast Cancer17
Outcomes of Women Undergoing Mastectomy for Unilateral Breast Cancer Who Elect to Undergo Contralateral Mastectomy for Symmetry: A Systematic Review17
Optimal Follow-Up of Sentinel Node Positive Melanoma Patients?17
Patterns of Survival and Recurrence in Poor Responders to Neoadjuvant Therapy for Gastric Cancer: A Real-World Multicenter Study17
Correction: The Comprehensive Complication Index for Assessing Short-Term Complications of Urothelial Carcinoma with Variant Histology: A Patient-Based Study17
Time to Discard the Staging Laparoscopy? Elucidating the Role for Routine Diagnostic Laparoscopy in Patients with Gastroesophageal Junction Malignancy17
ASO Author Reflections: Redefining Consolidation Cytoreductive Surgery for Ovarian Cancer17
ASO Visual Abstract: Albumin and Derived Neutrophil-To-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma17
Advances in Robot-Assisted Thoracoscopic Surgery: Demand for Precision17
ASO Author Reflections: A Practical Prediction Model for Clinically Relevant Post-Hepatectomy Liver Failure After Major Liver Resection for HCC17
Preoperative Frailty Assessment Predicts Postoperative Mortality, Delirium and Pneumonia in Elderly Lung Cancer Patients: A Retrospective Cohort Study17
ASO Visual Abstract: Completely Resectable (cT1-2) Esophageal Squamous Cell Carcinoma with Minimal Lymph Node Involvement (cN1): Is Neoadjuvant Chemoradiation Therapy the Only Viable Treatment Option?17
The Legacy of Jeff Norton: From Cachexia to the Earlier Detection of Pancreatic Cancer 36 Years of Mentoring a Surgical Scientist17
ASO Author Reflections: Toward the Prediction of Peritoneal Recurrence After Curative Resection for Colon Cancer17
ASO Author Reflections: Robotic Transabdominal Approach for Gastroesophageal Junction Cancers in the Era of Multidisciplinary Treatment17
ASO Author Reflections: Neoadjuvant Treatment for Melanoma—Where Are We Now?17
ASO Visual Abstract: Omitting Axillary Surgery for Patients with Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery17
ASO Visual Abstract: The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma In Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (T16
ASO Visual Abstract: Radiological Occult Metastases in Pancreatic Cancer—Analysis of Risk Factors and Survival Outcomes in the Age of Contemporary Neoadjuvant Multiagent Chemotherapy16
ASO Visual Abstract: Surgery Improves Patient-Reported Outcomes in Patients with Intestinal and Pancreatic NETs: A Prospective Analysis16
ASO Visual Abstract: The Association of Viral Hepatitis Status and Post-hepatectomy Outcomes in the Era of Direct-Acting Antivirals16
ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site?16
ASO Author Reflections: Arterial Ischemic Events Following Cancer Surgery: Where Do We Stand?16
ASO Author Reflections: Survival Outcomes of Patients with Esophageal Cancer and Post-chemoradiotherapy Surgical T4b Disease: Is Palliative Resection Justified?16
Disparate Tumor Characteristics and Survival Outcomes Between Squamous Cell and Adenocarcinoma Subtypes in Cholangiocarcinoma16
Prior Helicobacter Pylori Infection is Associated with Improved Survival for Hispanic Patients with Gastric Cancer16
Editorial Comment on: One-Year Experience of Same-Day Mastectomy and Breast Reconstruction Protocol16
ASO Visual Abstract: Outcomes for Patients with Obesity Undergoing Adrenalectomy for Pheochromocytoma—An International Multicenter Analysis16
ASO Visual Abstract: Dual-Layer Rotation: A Versatile Therapeutic Mammoplasty Technique16
ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer16
ASO Visual Abstract: Recurrence Patterns for Regionally Metastatic Melanoma Treated in the Era of Adjuvant Therapy: A Systematic Review and Meta-Analysis16
ASO Visual Abstract: PROMRIINE (PRe-operatory Magnetic Resonance Imaging is INEffective) Study: A Systematic Review and Meta-analysis of the Impact of Magnetic Resonance Imaging on Surgical Decisions 16
ASO Visual Abstract: Impact of Hepatic Pedicle Clamping on Long-Term Survival Following Hepatectomy for Hepatocellular Carcinoma: Stratified Analysis Based on Intraoperative Blood Transfusion Status16
ASO Author Reflections: The Advantages of Robotic Pancreaticoduodenectomy for Pancreatic Cancer16
ASO Visual Abstract: BREAST-Q REACT—Qualitative Assessment of the Design, Functionality, and Clinical Utility of a New Score Interpretation Tool16
Therapeutic Strategy by Neuronal Pentraxin Receptor for Esophageal Squamous Cancer Cells16
ASO Author Reflections: Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular Invasion After Hepatectomy16
ASO Visual Abstract: Effect of Minimally Invasive Versus Open Distal Gastrectomy on Long-Term Survival in Patients with Gastric Cancer: Individual Patient Data Meta-analysis16
ASO Author Reflections: Genetic Heterogeneity in HER2-Low Breast Cancers Reflects Different Treatment Responses16
ASO Visual Abstract: Comparison of EPIC Versus HIPEC in the Treatment of Colorectal Peritoneal Metastases and Appendix Tumors Using Inverse Probability of Treatment Weighting16
Quantity Over Quality? Dutch Surgeons’ Perceptions About Lymph Node Dissection During Minimally Invasive Esophagectomy16
ASO Visual Abstract: Application and Match Rates in the Complex General Surgical Oncology Match16
ASO Author Reflections: Intraoperative Radiation Therapy (IORT): Will It Survive in the USA?16
ASO Visual Abstract: Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal Cancer Patients16
ASO Visual Abstract: Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast16
Induction Therapy with Crizotinib Before Surgery for ROS1 Fusion-Positive Potentially Resectable Non-small Cell Lung Cancer15
0.25958800315857